Cidara Therapeutics (CDTX) Skyrockets 108.9% as Merck Acquisition Hits $221.50 Per Share
Cidara Therapeutics (NASDAQ:CDTX) is a clinical-stage biotechnology company founded with the mission of transforming the prevention and treatment…
Cidara Therapeutics (CDTX) Surges After Breakthrough Flu Trial—Is This the Future of Seasonal Protection?
Cidara Therapeutics, Inc. (NASDAQ:CDTX) is a San Diego-based, clinical-stage biotechnology company at the forefront of a new class…